Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer

Overview of attention for article published in Journal of Chemotherapy, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,131 followers.

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer https://t.co/Xy55nyAHh6

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer https://t.co/3z83ASDSHK https://t.co/WwutX9TKEF

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer https://t.co/QlkbaAz9bh

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer https://t.co/hEYTzEwe4G

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.